Summary:
- The article provides insights into the epilepsy pipeline, including ongoing clinical trials, treatment drugs, and companies involved in the development of new epilepsy therapies.
- It discusses the current landscape of epilepsy treatment and the need for more effective and safer drugs to manage the condition.
- The article highlights the various stages of drug development, from preclinical studies to late-stage clinical trials, and the potential impact of these new treatments on the lives of people with epilepsy.